IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+29.45%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
AUM
$368M
AUM Growth
+$368M
Cap. Flow
-$72.5M
Cap. Flow %
-19.73%
Top 10 Hldgs %
47.34%
Holding
127
New
24
Increased
22
Reduced
26
Closed
20
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BCLI
76
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$51K 0.01%
90,242
SYBX icon
77
Synlogic
SYBX
$17.4M
$36.6K ﹤0.01%
20,448
EYPT icon
78
EyePoint Pharmaceuticals
EYPT
$827M
$21.6K ﹤0.01%
1,047
-367,083
-100% -$7.59M
FNCH
79
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$18.1K ﹤0.01%
6,892
TYRA icon
80
Tyra Biosciences
TYRA
$657M
$8.22K ﹤0.01%
501
-47,669
-99% -$782K
ASLN
81
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$6.27K ﹤0.01%
35,420
LBPH
82
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$5.1K ﹤0.01%
236
-979,226
-100% -$21.2M
IMGN
83
DELISTED
Immunogen Inc
IMGN
-90,162
Closed -$2.67M
ICVX
84
DELISTED
Icosavax, Inc. Common Stock
ICVX
-440,000
Closed -$6.93M
KRTX
85
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
0
FUSN
86
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-500,000
Closed -$4.81M
TCON
87
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-2,765,530
Closed -$484K
MOR
88
DELISTED
MorphoSys AG American Depositary Shares
MOR
0
OKUR
89
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
-421,300
Closed -$674K
XHB icon
90
SPDR S&P Homebuilders ETF
XHB
$1.91B
-200,000
Closed -$19.1M
XBI icon
91
SPDR S&P Biotech ETF
XBI
$5.29B
0
VRDN icon
92
Viridian Therapeutics
VRDN
$1.59B
0
VKTX icon
93
Viking Therapeutics
VKTX
$3.02B
0
VERV
94
DELISTED
Verve Therapeutics
VERV
0
RCUS icon
95
Arcus Biosciences
RCUS
$1.24B
0
PTGX icon
96
Protagonist Therapeutics
PTGX
$3.62B
-319,000
Closed -$7.31M
PRTA icon
97
Prothena Corp
PRTA
$452M
0
NVAX icon
98
Novavax
NVAX
$1.2B
0
MRNA icon
99
Moderna
MRNA
$9.36B
-24,546
Closed -$2.44M
MLTX icon
100
MoonLake Immunotherapeutics
MLTX
$3.78B
0